![logo](/logos/000100.KS.webp)
Yuhan Corporation
KRX:000100.KS
126,700 (KRW) • At close September 6, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Yuhan Corporation |
Symbool | 000100.KS |
Munteenheid | KRW |
Prijs | 125,600 |
Beurswaarde | 9,268,522,757,600 |
Dividendpercentage | 0.64% |
52-weken bereik | 52,285.7 - 149,800 |
Industrie | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Wook-Je Cho |
Website | https://www.yuhan.co.kr |
An error occurred while fetching data.
Over Yuhan Corporation
Yuhan Corporation, a pharmaceutical company, engages in the research, development, and production of active pharmaceutical products and intermediates in South Korea and internationally. It offers antivirals, antibiotics, antihistamines, antidiabetics, beta-lactamase inhibitors, CNS intermediates, and PEGylated compounds; Revanex, an acid pump antagonist for the treatment of peptic ulcers and gastritis-related mucosal
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (KRW)
Cijfers zijn in miljoenen (KRW)